U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07362030) titled 'Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin' on Jan. 14.
Brief Summary: The drug-drug interaction study had been designed to investigate the effect of RAY1225 on the pharmacokinetics of digoxin, Rosuvastatin and
Study Start Date: April 14, 2025
Study Type: INTERVENTIONAL
Condition:
Obesity
Intervention:
DRUG: RAY1225
subcutaneous injection
DRUG: atorvastatin calcium tablet
Oral
DRUG: Metformin Tablets
Oral
DRUG: Warfarin Sodium Tablets
Oral
DRUG: Digoxin Tablets
Oral
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Guangdong Raynovent Biotech Co., Ltd
Disclaimer: Curated by...